June 1, 2020
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending that approval for the sodium-glucose cotransporter 2 […]
June 1, 2020
The Food and Drug Administration approved a medication for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. The medication, marketed as […]
April 16, 2020
The Food and Drug Administration has approved mitomycin (Jelmyto), the first therapy for adults with low-grade upper tract urothelial cancer. “This is the first approval specifically […]
April 9, 2020
The targeted agent encorafenib (Braftovi, Array BioPharma, now part of Pfizer) has been approved by the US Food and Drug Administration (FDA) for use in BRAF-positive […]
April 7, 2020
Boston Scientific is recalling their Imager II 5F angiographic catheters in the United States because the catheter tip could become detached during a patient procedure or during procedure […]
April 6, 2020
The US Food and Drug Administration (FDA) has updated the prescribing information for peginterferon β-1a (Plegridy, Biogen) and interferon β-1a (Avonex, Biogen) regarding use during pregnancy […]
April 6, 2020
The US Food and Drug Administration (FDA) has approved luspatercept (Reblozyl, Bristol-Myers Squibb/Acceleron) for the treatment of anemia in patients with myelodysplastic syndromes (MDS). The green light represents […]
April 4, 2020
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The U.S. Food and Drug Administration has granted Cellex an emergency use […]
April 3, 2020
The European Medicines Agency (EMA) has recommended a number of changes regarding the use of fosfomycin-based antibiotics, including recommending the suspension of use of pediatric and […]